We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Read about talking therapies and counselling for mental health problems.
This report sets out the work of the Gene Therapy Advisory Committee in 2010.
Development of the ENhancing Assessment of Common Therapeutic factors (ENACT) rating scale
An approach to payment for providers of IAPT services that links payment to patient outcomes as well as the provider’s levels of activity.
A rapid evidence assessment and qualitative study that aims to improve understanding of the practice, experience and effect of conversion therapy.
Systematic literature review reporting recommendations for safeguarding and protecting children.
How to get a marketing authorisation (MA) for an advanced therapy medicinal product (ATMP) so it can be sold and/or supplied in the United Kingdom.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).